Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies.

C.E. Hack, A. Relan, A. Baboeram, B. Oortwijn, S. Versteeg, R. van Ree, R. Pijpstra

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	275-281
Number of pages	7
Journal	Clinical Drug Investigation
Volume	33
Issue number	4
DOIs	https://doi.org/10.1007/s40261-013-0064-2
Publication status	Published - 2013

Access to Document

@article{2fad70a8c2de43e59fedf07b4beeeae4,

title = "Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies.",

author = "C.E. Hack and A. Relan and A. Baboeram and B. Oortwijn and S. Versteeg and {van Ree}, R. and R. Pijpstra",

year = "2013",

doi = "10.1007/s40261-013-0064-2",

language = "English",

volume = "33",

pages = "275--281",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis International Ltd",

number = "4",

}

TY - JOUR

T1 - Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies.

AU - Hack, C.E.

AU - Relan, A.

AU - Baboeram, A.

AU - Oortwijn, B.

AU - Versteeg, S.

AU - van Ree, R.

AU - Pijpstra, R.

PY - 2013

Y1 - 2013

U2 - 10.1007/s40261-013-0064-2

DO - 10.1007/s40261-013-0064-2

M3 - Article

C2 - 23463274

SN - 1173-2563

VL - 33

SP - 275

EP - 281

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 4

ER -